419 articles in this topic
New research reveals how genetic variants in PCSK9 dramatically reduce cardiovascular disease risk through improved cholesterol metabolism.
New cholesterol-lowering drugs target PCSK9 protein to dramatically reduce LDL levels and cardiovascular disease risk.
Study of 912 patients with severe genetic cholesterol disorder reveals blood pressure control remains crucial for heart health.
VR, AR, and mixed reality offer new ways to assess cognitive function and rehabilitate neurological conditions.
New research reveals how dopamine antagonists could prevent dangerous hypoglycemia unawareness in diabetic patients.
Researchers discover how cancer cells use metabolic enzyme PHGDH to evade immune detection, opening new combination therapy approaches.
Major trial shows evolocumab reduces cardiovascular events by 22% in diabetic patients, offering new prevention strategy.
New study shows evolocumab significantly reduces cardiovascular events in diabetes patients, offering powerful prevention strategy.
Major cardiology groups recommend cholesterol screening in childhood for some, plus new genetic risk factors like lipoprotein(a) testing.
Leading cardiologists highlight persistent challenges in determining optimal lipid-lowering strategies for cardiovascular disease prevention.
The Lancet announces comprehensive commission to address the growing global burden of colorectal cancer through prevention and treatment strategies.
New analysis challenges assumptions about sudden cardiac death risk in heart failure patients with preserved pumping ability.
